PRODUCT OVERVIEW & COMPOSITION
Brand / Manufacturer: Bioniche Pharma
Active Ingredient: Oxandrolone USP (10 mg per tablet)
Pharmacological Class: Synthetic Anabolic-Androgenic Steroid ($17\alpha$-alkylated Dihydrotestosterone derivative)
Bioniche Pharma Oxandrolone is an orally active anabolic steroid featuring a uniquely modified heterocyclic structure ($17\alpha$-methylated and $2$-oxa substituted DHT derivative). Designed to maximize tissue-building potential while minimizing androgenic activity, it enhances protein synthesis and nitrogen retention without converting into estrogen.
CLINICAL PHARMACOLOGY & DYNAMICS
Bioniche Pharma Oxandrolone acts by binding to cellular androgen receptors, triggering gene expression that drives protein accretion and inhibits muscle catabolism. While designed with a high anabolic-to-androgenic ratio, complete separation of anabolic properties from androgenic effects is clinically unachievable; thus, mild androgenic responses may still occur depending on dosage and patient sensitivity.
INDICATIONS & CLINICAL USE
- Adjunctive therapy to restore body weight and lean muscle tissue lost following major surgical procedures, severe physical trauma, or chronic infectious states using Bioniche Pharma formulations.
- Palliative support to offset severe catabolic state induced by prolonged corticosteroid administration under Bioniche Pharma medical supervision.
- Management of involuntary weight loss or inability to maintain healthy body mass without clear underlying pathophysiological etiology utilizing Bioniche Pharma products.
CONTRAINDICATIONS
- Confirmed or suspected carcinoma of the prostate gland or male breast.
- Breast carcinoma in female patients accompanied by hypercalcemia (androgenic anabolic agents can accelerate osteolytic bone resorption).
- Pregnancy and lactation due to fetal masculinization risks.
- Known hypersensitivity to Bioniche Pharma Oxandrolone or any inactive formulation components.
DOSAGE & ADMINISTRATION
Dosing protocols for Bioniche Pharma Oxandrolone must be individualized and administered under strict medical supervision. Regimens depend on patient body weight, clinical objectives, and ongoing laboratory monitoring.
ADVERSE REACTIONS & HEPATIC WARNINGS
Although generally considered a milder $17\alpha$-alkylated agent, monitoring for potential systemic and hepatic adverse events remains necessary during Bioniche Pharma therapy:
- Hepatic Effects: Potential for cholestatic jaundice, hepatic enzyme elevations, and in rare severe instances, hepatic necrosis or failure associated with Bioniche Pharma administration. Prolonged or high-dose therapy increases the risk of peliosis hepatis and hepatocellular neoplasms.
- Endocrine & Lipid Profile: Dose-dependent suppression of serum HDL cholesterol and elevation of LDL cholesterol, as well as transient suppression of endogenous gonadotropins during Bioniche Pharma treatment.
- Dermatological & Androgenic: Mild acne, oily skin, or virilization signs in females upon prolonged exposure to Bioniche Pharma Oxandrolone.
STORAGE & HANDLING
Store Bioniche Pharma products in a cool, dry place shielded from direct light exposure and excess moisture. Keep strictly out of reach and sight of children.